Promising nanotherapy in treating leishmaniasis

Volume: 547, Issue: 1-2, Pages: 421 - 431
Published: Aug 1, 2018
Abstract
Leishmaniases are infectious diseases caused by an intracellular protozoan in humans by 20 different species of Leishmania among more than 53 species. There are at least twelve million cases of infections worldwide and three hundred and fifty million people are at risk in at least 98 developing countries in Africa, South-East Asia, and the Americas. Only Brazil presented high burden for both visceral leishmaniasis (VL) and cutaneous (CL)....
Paper Details
Title
Promising nanotherapy in treating leishmaniasis
Published Date
Aug 1, 2018
Volume
547
Issue
1-2
Pages
421 - 431
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.